The results showed increased IL-18 levels in patients who developed CI-AKI, reaching near statistical significance at 24 h; however, levels declined by 72 h, suggesting limited reliability of serum IL-18 as a sustained biomarker for CI-AKI [ 78 ].
← all excerpts
Update on Contrast-Induced Nephropathy: Recent Developments in Its Prevention, Early Diagnosis, and Therapy.
1
—
—